Disseminated Histoplasmosis in Corticosteroid-Treated Patients
- 29 September 1978
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 240 (14) , 1495-1498
- https://doi.org/10.1001/jama.1978.03290140037018
Abstract
AlthoughHistoplasma capsulatumis not generally considered an opportunistic organism, we have seen five corticosteroid-treated patients in whom disseminated histoplasmosis (DH) developed. Persistent, unexplained fever was the predominant symptom in each. Death was directly attributable to DH in four. The interval from onset of symptoms to diagnosis ranged from 11 to 75 days; delay in diagnosis adversely affected prognosis. Culture of the bone marrow appears to be the best diagnostic study. The pathologic features of DH in immunocompromised hosts are the presence of large numbers ofHistoplasmayeast forms within macrophages, absence of discrete granulomas, and a reduced or absent inflammatory response.Histoplasma capsulatumshould be considered as a possible cause in any immunosuppressed patient with unexplained fever, especially if the patient has been receiving corticosteroid therapy. (JAMA240:1495-1498, 1978)Keywords
This publication has 5 references indexed in Scilit:
- Disseminated histoplasmosis and childhood leukemiaCancer, 1974
- Endogenous exacerbation of histoplasmosis after apparent recovery from an acute pulmonary infection.Published by Elsevier ,1971
- Fungal infections complicating acute leukemiaJournal of Chronic Diseases, 1966
- THE EFFECTS OF CORTISONE ON EXPERIMENTAL FUNGUS INFECTIONS*Annals of the New York Academy of Sciences, 1960
- Fatal Fungus Infections Complicating Other DiseasesAmerican Journal of Clinical Pathology, 1955